(Q44431632)

2 December 2017

Effects of hormone replacement therapy on circulating docosahexaenoic acid and eicosapentaenoic acid levels in postmenopausal women (English)

1 reference

2 December 2017

Effects of Hormone Replacement Therapy on Circulating Docosahexaenoic Acid and Eicosapentaenoic Acid Levels in Postmenopausal Women (English)

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Hormone Replacement Therapy

30 December 2023

main subject

1 reference

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

30 December 2023

7

Hideki Mizunuma

1 reference

2 December 2017

Hiroyuki Sumino

1

1 reference

2 December 2017

Shuichi Ichikawa

2

1 reference

2 December 2017

Masami Murakami

3

1 reference

2 December 2017

Tetsuya Nakamura

4

1 reference

2 December 2017

Tsugiyasu Kanda

5

1 reference

2 December 2017

Tetsuo Sakamaki

6

1 reference

2 December 2017

Masahiko Kurabayashi

8

1 reference

2 December 2017

language of work or name

1 reference

1 February 2003

1 reference

2 December 2017

1 reference

2 December 2017

50

1 reference

2 December 2017

1

1 reference

2 December 2017

51-59

1 reference

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

2 December 2017

1

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

30 December 2023

2

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

30 December 2023

3

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

30 December 2023

4

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study

30 December 2023

5

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial

30 December 2023

6

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins

30 December 2023

7

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women

30 December 2023

8

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

30 December 2023

9

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women

30 December 2023

10

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Serum level of vascular endothelial growth factor is decreased by hormone replacement therapy in postmenopausal women without hypercholesterolemia

30 December 2023

12

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

The protective effects of estrogen on the cardiovascular system

30 December 2023

13

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

30 December 2023

Acta medica Scandinavica

14

200

69

Bang HO, Dyerberg J, Hjorne N

publication date

1976

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Prophylaxis of atherosclerosis with marine omega-3 fatty acids. A comprehensive strategy

30 December 2023

15

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

30 December 2023

16

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Eicosapentaenoic acid and docosahexaenoic acid suppress the proliferation of vascular smooth muscle cells

30 December 2023

17

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial

30 December 2023

19

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia.

30 December 2023

20

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Cardiovascular Effects of n-3 Fatty Acids

30 December 2023

22

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Dietary fish oil confers direct antiarrhythmic properties on the myocardium of rats

30 December 2023

24

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Images in Cardiovascular Medicine. Chloroquine-induced cardiomyopathy

30 December 2023

25

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Serum fatty acids and the risk of coronary heart disease

30 December 2023

27

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

n-3 fatty acids in adipose tissue and coronary artery disease are inversely related

30 December 2023

28

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

The cardiovascular protective role of docosahexaenoic acid

30 December 2023

29

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Dietary docosahexaenoic acid is retroconverted in man to eicosapentaenoic acid, which can be quickly transformed to prostaglandin I3

30 December 2023

30

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects

30 December 2023

31

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitus.

30 December 2023

33

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Oestradiol-induced changes in the composition of phospholipid classes of quail oviduct: specific replacement of arachidonic acid by docosahexaenoic acid in alkenylacyl-glycerophosphoethanolamine

30 December 2023

34

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Decreased levels of polyunsaturated fatty acids in preeclampsia

30 December 2023

35

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

30 December 2023

36

1 reference

https://api.crossref.org/works/10.1507/ENDOCRJ.50.51

30 December 2023

Identifiers

1 reference

2 December 2017

1 reference